Lindbrook Capital’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $18K | Buy |
819
+13
| +2% | +$286 | ﹤0.01% | 1400 |
|
|
2024
Q4 | $18.3K | Buy |
806
+532
| +194% | +$12.1K | ﹤0.01% | 1333 |
|
|
2024
Q3 | $4.98K | Sell |
274
-638
| -70% | -$11.6K | ﹤0.01% | 2016 |
|
|
2024
Q2 | $26.6K | Buy |
912
+862
| +1,724% | +$25.1K | ﹤0.01% | 1085 |
|
|
2024
Q1 | $1.77K | Sell |
50
-7
| -12% | -$248 | ﹤0.01% | 2286 |
|
|
2023
Q4 | $2.48K | Sell |
57
-200
| -78% | -$8.71K | ﹤0.01% | 2194 |
|
|
2023
Q3 | $9.82K | Buy |
257
+135
| +111% | +$5.16K | ﹤0.01% | 1429 |
|
|
2023
Q2 | $5.02K | Sell |
122
-158
| -56% | -$6.5K | ﹤0.01% | 1805 |
|
|
2023
Q1 | $16.1K | Buy |
280
+12
| +4% | +$689 | ﹤0.01% | 1182 |
|
|
2022
Q4 | $15K | Buy |
268
+86
| +47% | +$4.82K | ﹤0.01% | 1221 |
|
|
2022
Q3 | $8K | Buy |
182
+13
| +8% | +$571 | ﹤0.01% | 1429 |
|
|
2022
Q2 | $9K | Buy |
169
+1
| +0.6% | +$53 | ﹤0.01% | 1305 |
|
|
2022
Q1 | $11K | Buy |
168
+13
| +8% | +$851 | ﹤0.01% | 1245 |
|
|
2021
Q4 | $10K | Hold |
155
| – | – | ﹤0.01% | 1266 |
|
|
2021
Q3 | $11K | Hold |
155
| – | – | ﹤0.01% | 959 |
|
|
2021
Q2 | $11K | Hold |
155
| – | – | ﹤0.01% | 1012 |
|
|
2021
Q1 | $11K | Hold |
155
| – | – | ﹤0.01% | 978 |
|
|
2020
Q4 | $10K | Hold |
155
| – | – | ﹤0.01% | 906 |
|
|
2020
Q3 | $7K | Hold |
155
| – | – | ﹤0.01% | 960 |
|
|
2020
Q2 | $7K | Hold |
155
| – | – | ﹤0.01% | 962 |
|
|
2020
Q1 | $7K | Buy |
155
+119
| +331% | +$5.37K | ﹤0.01% | 872 |
|
|
2019
Q4 | $2K | Hold |
36
| – | – | ﹤0.01% | 1290 |
|
|
2019
Q3 | $2K | Hold |
36
| – | – | ﹤0.01% | 1261 |
|
|
2019
Q2 | $2K | Hold |
36
| – | – | ﹤0.01% | 1231 |
|
|
2019
Q1 | $2K | Hold |
36
| – | – | ﹤0.01% | 1227 |
|
|
2018
Q4 | $1K | Buy |
+36
| New | +$1K | ﹤0.01% | 1261 |
|